synergy nash tirzepatide nafld Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with Pharmacotherapy for Non-alcoholic Fatty Liver – Nearly 62% achieve MASH resolution

Insurance rarely covers Ozempic or other GLP-1 medications, telehealth providers charge hundreds of dollars per month and local medical spas can charge even more

It is a smaller peptide and is generally subject to relatively rapid metabolic clearance

Each OZEMPIC pen is for use by a single patient

Seven days after a dose, around 44% of that dose's peak remains, and accumulation across weekly doses keeps steady-state levels high enough to stay pharmacologically active throughout the week

Distribution Channel, Retail Pharmacies Lead, And Online Pharmacies Grow the Fastest The retail pharmacies held the largest revenue share of around 56.61% in the semaglutide market in 2024, owing to easy availability, robust distribution, and increasing consumer inclination for easy prescription refill orders